Filter
2095
Filtered Results: 2095
Text search:
cardiovascular
diseases
Featured
Recommendations
201
New Publications
448
Language
Document type
No document type
930
Studies & Reports
494
Guidelines
347
Manuals
98
Strategic & Response Plan
75
Fact sheets
71
Training Material
35
Resource Platforms
13
Dashboards/Maps
8
Situation Updates
7
Infographics
7
Videos
5
Brochures
3
App
1
Online Courses
1
Countries / Regions
Global
158
India
109
Latin America and the Carribbean
53
Kenya
51
Western and Central Europe
43
South Africa
41
Brazil
39
Ethiopia
37
Ukraine
32
Philippines
31
Ghana
28
Nigeria
27
Africa
27
Nepal
24
Tanzania
23
Rwanda
22
Indonesia
21
Malawi
20
Syria
19
Bangladesh
19
Namibia
18
Zambia
18
Myanmar / Burma
18
Venezuela
17
South–East Asia Region
17
Colombia
16
Chile
16
Sierra Leone
15
Uganda
15
Paraguay
14
Lesotho
13
North America
13
Eastern Europe
13
Russia
13
Cambodia
12
Asia
12
Liberia
12
Mozambique
11
Botswana
11
Eswatini/ Swaziland
11
Eastern Europe and Central Asia
10
Ecuador
10
Zimbabwe
9
Germany
9
Argentina
9
Peru
8
Middle East and North Africa
8
East and Southern Africa
8
Bolivia
7
USA
6
West and Central Africa
6
Haiti
5
Congo, Democratic Republic of
5
Spain
5
Angola
5
Albania
4
Western Pacific Region
4
United Kingdom
4
Portugal
4
Vietnam
4
Papua New Guinea
4
Moldova
4
North Macedonia
3
Thailand
3
Mexico
3
Turkey
3
Laos
3
Senegal
3
Kyrgyzstan
3
Yemen
3
Iraq
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Kazakhstan
2
Cameroon
2
Iran
2
Afghanistan
2
Guinea
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Jamaica
2
France
2
Bosnia and Herzegovina
2
Lebanon
2
Sudan
2
Palestine
2
Libya
2
South Sudan
2
Somalia
2
Madagascar
2
Switzerland
1
Timor Leste/ East Timor
1
Togo
1
Fiji
1
Burkina Faso
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Lithuania
1
Ireland
1
Turkmenistan
1
Mauritius
1
Azerbaijan
1
Israel
1
Latvia
1
Southern Africa
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Georgia
1
Bhutan
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Countries
866
Public Health
283
Clinical Guidelines
218
Women & Child Health
64
Capacity Building
47
Key Resources
44
Pharmacy & Technologies
7
Annual Report MEDBOX
1
Toolboxes
NCDs
291
COVID-19
243
Mental Health
189
Planetary Health
134
HIV
65
Global Health Education
53
Caregiver
51
Pharmacy
47
Disability
37
Conflict
37
TB
36
NTDs
35
Refugee
27
Rapid Response
24
AMR
19
Health Financing Toolbox
8
Specific Hazards
7
Natural Hazards
7
Ebola & Marburg
7
Cholera
6
Social Ethics
3
Zika
3
Polio
2
Monitoring is a crucial element in any successful programme. It is important to
know if health care facilities – and ultimately countries – are meeting the agreed
goals and objectives for preventing and managing cardiovascular diseases (CVD).
Monitoring is the on-going collection, management ...
CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cauAn estimated 17.5 m
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its variation within countries by socio-demographic char...
Age-standardized cardiovascular disease (CVD) mortality rates by region ranged from 73.6 per 100,000 in High-income Asia Pacific to 432.3 per 100,000 in Eastern Europe in 2022. Global CVD mortality decreased by 34.9% from 1990 to 2022. Ischemic heart disease had the highest global age-standardized D...
Key facts
- Cardiovascular diseases (CVDs) are the leading cause of death globally.
- An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
- Over three quarters of CVD deaths take place in low- an...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Development of cardiovascular disease (CVD) is influenced by risk factors such as:
tobacco use, an unhealthy diet, physical inactivity, obesity (which can result from
a combination of unhealthy diet, physical inactivity, and other factors), elevated
blood pressure (hypertension), abnormal blood l...
HEARTS provides a set of locally adaptable tools for strengthening the
management of CVD in primary health care.
HEARTS is designed to enhance implementation of WHO PEN by providing:
• operational guidance on further integrating CVD management
• technical guidance on evaluating the impact of...
Background
In the prevention of cardiovascular disease, a WHO target is that at least 50% of eligible people use statins. Robust evidence is needed to monitor progress towards this target in low-income and middle-income countries (LMICs), where most cardiovascular disease deaths occur. The objectiv...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
The article "Can we prevent cardiovascular diseases in low- and middle-income countries?" by Claude Lenfant discusses the growing threat of cardiovascular diseases (CVDs) in developing countries. It highlights that while CVD is already the leading cause of death globally, low- and middle-income coun...
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
Cardiovascular disease, heart disease, and coronary heart disease may sound similar but they are not one in the same. This fact sheet will help you understand how these conditions differ.
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
